Search Results - "Porta, Daniela J."

Ibuprofen, a traditional drug that may impact the course of COVID-19 new effective formulation in nebulizable solution by García, Néstor H., Porta, Daniela J., Alasino, Roxana V., Muñoz, Sonia E., Beltramo, Dante M.

“…The traditional formulation of ibuprofen is poorly soluble in water, so the administered dose must be 10 times higher than the dose required for a therapeutic…”
Get full text

Pharmacoinformatics studies of coenzyme Q10 and potassium polyacrylate on angiotensin-converting enzyme associated with hypertension by Adeoye, Akinwunmi O., Porta, Daniela J., Rivoira, María A., Garcia, Néstor H.

“…Coenzyme Q10's (CoQ10) favorable impact on cardiovascular diseases risk factors like hypertension and atherosclerosis is linked to the antioxidant action of…”
Get full text

Atherosclerosis plaque area reduction: working hypothesis to prevent cardiovascular event by Perez, Hernán A., Allende, Gustavo Flores, Ajayi, Ebenezer I. O., Porta, Daniela J., García, Néstor H.

“…Cardiovascular events are the leading cause of death worldwide. In this sense, cardiovascular diseases (CVD) are the main products of atherosclerosis (ATR),…”
Get full text

Reversal of SARS-CoV2-Induced Hypoxia by Nebulized Sodium Ibuprofenate in a Compassionate Use Program by Salva, Oscar, Doreski, Pablo A., Giler, Celia S., Quinodoz, Dario C., Guzmán, Lucia G., Muñoz, Sonia E., Carrillo, Mariana N., Porta, Daniela J., Ambasch, Germán, Coscia, Esteban, Diaz, Jorge L. Tambini, Bueno, Germán D., Fandi, Jorge O., Maldonado, Miriam A., Peña Chiappero, Leandro E., Fournier, Fernando, Pérez, Hernán A., Quiroga, Mauro A., Sala Mercado, Javier A., Martínez Picco, Carlos, Beltrán, Marcelo Alejandro, Argañarás, Luis A., Ríos, Nicolás Martínez, Kalayan, Galia I., Beltramo, Dante M., García, Néstor H.

“…Introduction Sodium ibuprofenate in hypertonic saline (NaIHS) administered directly to the lungs by nebulization and inhalation has antibacterial and…”
Get full text

Assessment of total carotid plaque area progression in patients with chronic kidney disease. Good practices for decision-making by Porta, Daniela J, Carrillo, Mariana N, Pérez, Hernán A, Rivoira, María A, Ledesma, Grisel N, Muñoz, Sonia E, Aballay, Laura R, Armando, Luis J, Schelling, Jeffrey R, Spence, J David, García, Néstor H

“…Chronic kidney disease (CKD) increases cardiovascular risk, however, traditional cardiovascular risk factors cannot entirely explain it. A real-world…”
Get full text